Transition Agreements in the Biotechnology Industry

134 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
TRANSITION SERVICES AGREEMENT
Transition Agreements
Nuo Therapeutics, Inc.
Biotechnology
DE
2016
Transition Services Agreement, dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc
Transition Agreements
Passage BIO, Inc.
Biotechnology
PA
2024
Transition Services and General Release Agreement for Merdad Parsey, dated July 16, 2024
Transition Agreements
Gilead Sciences
Biotechnology
CA
2024
Transition and Release Agreement, dated September 25, 2024, by and between Julie Feder and the Registrant
Transition Agreements
Aura Biosciences, Inc.
Biotechnology
MA
2024
Transition Agreement, dated August 3, 2024, between the Registrant and Hiroomi Tada, M.D., Ph.D
Transition Agreements
Tyra Biosciences, Inc.
Biotechnology
CA
2024
Transition Services Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Nestlé Enterprises S.A
Transition Agreements
Seres Therapeutics, Inc.
Biotechnology
DE
2024
Executive Transition Agreement, dated September 23, 2024, by and between the Company and Stephen R. Davis
Transition Agreements
ACADIA PHARMACEUTICALS INC
Biotechnology
CA
2024
Transition Agreement, dated as of August 29, 2024, between the Company and Michael Mason
Transition Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2024
Form of Transition Services Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A
Transition Agreements
Seres Therapeutics, Inc.
Biotechnology
DE
2024
Transition Agreement, dated August 3, 2024, by and between Esperion Therapeutics, Inc. and JoAnne Foody
Transition Agreements
Esperion Therapeutics, Inc.
Biotechnology
DE
2024
Transition Agreement between the Registrant and Shafique Virani
Transition Agreements
RECURSION PHARMACEUTICALS, INC.
Biotechnology
FL
2024
Termination and Transition Agreement to Development and Commercialization Agreement (for the U.S. and Certain Other Territories), by and between AstraZeneca AB and FibroGen, Inc.,...
Transition Agreements
FIBROGEN INC
Biotechnology
2024
Employee Relocation and Transition Benefits Agreement, by and between AVROBIO, Inc. and Azadeh Golipour, dated January 31, 2022
Transition Agreements
AVROBIO, Inc.
Biotechnology
MA
2024
Transition Services Agreement, dated as of November 13, 2023, by and between Mural Oncology, Inc. and Alkermes, Inc
Transition Agreements
Alkermes plc.
Biotechnology
PA
2023
Transition Services Agreement, dated as of November 13, 2023, by and between Alkermes, Inc. and Mural Oncology, Inc
Transition Agreements
Alkermes plc.
Biotechnology
DE
2023
Transition and Release Agreement, dated November 6, 2023, by and between Cadmus Rich and the Registrant
Transition Agreements
Aura Biosciences, Inc.
Biotechnology
MA
2023
Transition and Release Agreement, dated September 28, 2023, by and between Cadmus Rich and the Registrant
Transition Agreements
Aura Biosciences, Inc.
Biotechnology
MA
2023
Transition Agreement between the Registrant and Marshelle Smith Warren, dated October 3, 2023
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between the Registrant and Lawrence Knopf, dated October 3, 2023
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between the Registrant and Richard Capasso, dated October 3, 2023
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between the Registrant and Howard Bernstein, dated October 3, 2023
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement effective as of August 22, 2023 by and between CytomX Therapeutics, Inc., and AbbVie Global Enterprises Ltd
Transition Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2023
Transition Agreement b
Transition Agreements
Deciphera Pharmaceuticals, Inc.
Biotechnology
MA
2023
Amendment to Transition Services Agreement between Eisai Inc., a subsidiary of Eisai and the Company, dated as of July 31, 2023 (certain identified information has been excluded...
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2023
Amendments 1, 2 and 3 to License and Transition Services Agreement with Forma Therapeutics, Inc
Transition Agreements
RIGEL PHARMACEUTICALS INC
Biotechnology
2023
TRANSITION SERVICES AGREEMENT
Transition Agreements
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2023
Transition Agreement and Release by and between the Company and Sunil Agarwal, dated as of April 28, 2023
Transition Agreements
Sana Biotechnology, Inc.
Biotechnology
CA
2023
Transition Agreement, by and between the Company and John Dobak, dated March 1, 2023
Transition Agreements
Constellation Alpha Capital Corp.
Biotechnology
CA
2023
Transition Agreement dated February 21, 2023, by and between the Company and John Magnani, Ph.D
Transition Agreements
GLYCOMIMETICS INC
Biotechnology
MD
2023
Transition and Release Agreement, by and between Fresh Tracks Therapeutics, Inc. and Robert B. Brown, dated as of February 1, 2023
Transition Agreements
VICAL INC
Biotechnology
2023
Form of Transition Services Agreement between Eisai, Inc., a subsidiary of Eisai, and the Company (certain identified information has been excluded from the exhibit because it...
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Transition Agreement, by and between the Registrant and Suzanne T. Ildstad, dated August 13, 2022
Transition Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Transition Agreement, by and between the Company and Eric Richman, dated September 19, 2022
Transition Agreements
Gain Therapeutics, Inc.
Biotechnology
MD
2022
Transition Agreement and Release, dated as of August 14, 2022, by and between Cara Cassino, M.D. and ContraFect Corporation
Transition Agreements
CONTRAFECT Corp
Biotechnology
NY
2022
Amendment to the Transition Services Agreement, by and between 2seventy bio, Inc. and the Registrant
Transition Agreements
bluebird bio, Inc.
Biotechnology
2022
Transition Agreement dated July 26, 2022, by and between Praxis Precision Medicines, Inc. and Bernard Ravina
Transition Agreements
Praxis Precision Medicines, Inc.
Biotechnology
MA
2022
Transition Services Agreement, dated as of
Transition Agreements
VICAL INC
Biotechnology
2022
Transition Agreement, dated March 28, 2022, between the Company and Sharon Shacham
Transition Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2022
Transition Agreement, dated March 28, 2022, between the Company and Michael G. Kauffman
Transition Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2022
Transition Agreement and Release dated March 22, 2022 between the Company and Mark Kowalski
Transition Agreements
Sierra Oncology, Inc.
Biotechnology
MA
2022
Transition Agreement and Release between the Registrant and David Hilbert, Ph.D., dated January 7, 2022
Transition Agreements
Arcellx, Inc.
Biotechnology
MD
2022